Selcia
Situation
When Selcia’s owner were approached regarding a potential acquisition, InterPharmaLink was mandated to assess, prepare and execute the transaction on behalf of the sell-side
Challenges
Within few weeks compelling information packages needed to be prepared to substantiate Selcia’s future growth prospects and value potential
Within few weeks historic financials and business plan projections needed to be upgraded to fit the requirements of a M&A and DD process
Within few weeks additional buyer candidates needed to be engaged to promote competition
Deliverables
Preparation of information packages and required financial data
Management and facilitation of the DD process and Q&A handling
Negotiation of the Letter of Intent, Term Sheet, and definitive Sale and Purchase Agreement
Impact
Successful sale of Selcia to Eurofins for an undisclosed amount in January 2018
Successful integration of Selcia’s world leading radio-labelling capabilities into the Eurofins group of companies